According to the financial report, last year, Small launched a new generation of automatic production line independently developed, which realized the automatic production of the whole production line such as assembly, liquid injection and packaging. Its single-line production efficiency can reach 7200 standard atomizers per hour, which has exceeded the industry level and taken the lead in large-scale application to core customers.
In addition, the revenue of TOB business for corporate customers exceeded10 billion yuan for the first time last year, reaching 654.38+02.59 billion yuan, up 37.4% year-on-year; The revenue from TOC business of retail customers was 65,438+065,438+060 million yuan, a year-on-year increase of 3,765,438+0%.
202 1 The overall financial report shows that Smear's expenditure on R&D has increased by nearly 60%. At present, 3408 patents have been applied, covering four technical types: temperature control, heater, liquid leakage prevention and liquid storage. Last year, there were 1 187 new patent applications in the world, an increase of 60% over the previous year, most of which were around.
Judging from the specific investment ratio, in 20021year, Smear invested 670 million yuan in R&D expenses, up 59.7% year-on-year. R&D's main investments are concentrated in cutting-edge materials science, fluid mechanics, aerodynamics, thermodynamics and other fields.
Among them, seven basic science research institutes established in China and the United States have been put into operation. By the end of 20021,smear had R&D personnel 1254 people, including * * *1kloc-0/person with doctoral degree or above, which increased by 47% and 2 15% respectively compared with last year.
According to Sullivan's relevant report, in 20021year, Smear's share in the global market continued to expand, reaching 22.8%, exceeding the sum of the second to fifth places. The report also pointed out that the global electronic atomization equipment market will grow rapidly in the next five years, with a compound growth rate of 24.6%. However, the report from Zhiyan Consulting pointed out that by 2024, the share of atomized products will be only 9.3%.
To this end, Xiaodi plans to realize the full category layout of atomized products in 2022. At the same time, Small will also enter the disposable category overseas in 2022. The financial report shows that Small will also carry out new exploration and layout in the fields of medical care and beauty, and is cooperating with well-known teams at home and abroad to develop medical care, beauty and other related products, which are expected to be introduced to the market soon.
After the meeting, the titanium media App interviewed the small executives. Facing the new policy of "Administrative Measures for Electronic Cigarettes" to be implemented on May 1, Small thinks that the new policy restricts multi-flavor products, and now users have different preferences for cigarette-flavor products, which is bound to have a certain impact on the China market.
However, for overseas markets such as Europe and America, multi-flavor products are still the mainstream, and Small is still optimistic about its overseas market business. In 2023 and beyond, as users in the domestic market get used to tobacco-flavored products, the relevant domestic markets in Smallville will definitely pick up.
In addition, Small also said that the previously established taste laboratory will not stagnate. For the global market, we will continue to research and develop products with various flavors to ensure the share of the global market. For the domestic market, it focuses on the research and development and continuous improvement of tobacco flavor products.
When talking about other scene applications other than electronic atomizers, Smear also revealed that the current research and development direction is not only in the field of medical atomizers, but also aimed at developing pharmaceutical combination products. The atomizer has been studied for 2 years, and now it has also made a breakthrough in atomizing drugs. Atomizers in other fields have been laid out in three directions: medical treatment, health and beauty.